Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, SVY

Sterile Pollen Technique Shows Promise for Palmer Amaranth Weed Control


Palmer amaranth remains among the most detrimental weeds in North American agriculture, and its resistance to several herbicide groups makes its control a serious challenge. Recently published research in the journal Weed Science shows that a sterilization technique commonly used to control insect pests can be modified to control weeds that require pollination to reproduce. More specifically, the researchers determined that employing a sterile pollen technique (SPT) could effectively disrupt Palmer amaranth (Amaranthus palmeri S.) reproduction.

WESTMINSTER, Colo., May 22, 2024 /PRNewswire-PRWeb/ -- Recently published research in the journal Weed Science shows that a sterilization technique commonly used to control insect pests can be modified to control weeds that require pollination to reproduce. More specifically, the researchers determined that employing a sterile pollen technique (SPT) could effectively disrupt Palmer amaranth (Amaranthus palmeri S.) reproduction.

"Our results indicate that SPT, using irradiated pollen, can be a valuable approach for reducing weed-seed production," says Mohsen B. Mesgaran, Ph.D., a plant sciences assistant professor at the University of California Davis, and the article's corresponding author.

Palmer amaranth remains among the most detrimental weeds in North American agriculture, and its resistance to several herbicide groups makes its control a serious challenge. Yet, researchers in this study were able to find a promising new control method for Palmer amaranth and possibly for many other difficult-to-control weeds.

"Our results indicate that SPT, using irradiated pollen, can be a valuable approach for reducing weed-seed production," says Mohsen B. Mesgaran, Ph.D., a plant sciences assistant professor at the University of California Davis, and the article's corresponding author. "SPT also holds potential for broad-spectrum weed control by mixing sterile pollen from multiple weed species in a single application."

Additionally, the researchers found that SPT shows promise for managing troublesome herbicide-resistant weeds that have survived in-season control efforts. "We observed the greatest reduction in seed set when irradiated pollen was introduced to the stigma through artificial pollination prior to open pollination," notes Mesgaran. "It appears that irradiated pollen exerts a preventive effect on naturally occurring pollen that arrives later."

While the researchers determined that a dose of 300 units of ionizing radiation (Gy) strikes the optimal balance to achieve both efficient Palmer amaranth pollination and seed sterility, challenges still remain. For example, irradiated pollen is currently less competitive than naturally occurring pollen. Thus, field managers may need to employ additional measures to successfully control Palmer amaranth with SPT, such as dispersing irradiated pollen in the field before male anthesis and releasing it multiple times.

More information about SPT and Palmer amaranth control can be found in the article, "Exploring sterile pollen technique as a novel tool for management of Palmer amaranth (Amaranthus palmeri)." The research is featured in Volume 72, Issue 3 of Weed Science, a Weed Science Society of America journal, published online by Cambridge University Press.

About Weed Science
Weed Science is a journal of the Weed Science Society of America, a nonprofit scientific society focused on weeds and their impact on the environment. The publication presents peer-reviewed original research related to all aspects of weed science, including the biology, ecology, physiology, management and control of weeds. To learn more, visit http://www.wssa.net.

Media Contact

William Vencill, PhD, Editor - Weed Science, 706-247-9890, [email protected], https://www.wssa.net/ 

SOURCE Weed Science


These press releases may also interest you

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...



News published on and distributed by: